reports
- James Carthew
QuotedData’s Investment Companies Quarterly Review – First quarter of ...
2024 started on strong footing, with global equities (as measured by the MSCI All Countries World Index) rallying 9.2% over the first three months (in sterling terms). However, while there some standouts in the emerging world, global equity returns were overwhelmingly driven by developed market companies. Inflation and interest rate expectations were once again a major influence on returns. Bond yields rose over the first quarter. There was, until recently, a general consensus that inflation wa...
EQS-News: Porsche AG kicks off a year of product launches with determi...
EQS-News: Dr. Ing. h.c. F. Porsche AG / Key word(s): Quarterly / Interim Statement Porsche AG kicks off a year of product launches with determination (news with additional features) 26.04.2024 / 17:30 CET/CEST The issuer is solely responsible for the content of this announcement. Porsche AG kicks off a year of product launches with determination Group operating return on sales is 14.2 per cent Ramp-ups of the new Panamera and Taycan models impact results CFO Lutz Meschke: “Even in challenging times, our financial strength allows us to invest decisively in our future. W...
EQS-News: Porsche AG startet entschlossen in das Jahr der Modelloffens...
EQS-News: Dr. Ing. h.c. F. Porsche AG / Schlagwort(e): Quartals-/Zwischenmitteilung Porsche AG startet entschlossen in das Jahr der Modelloffensiven (News mit Zusatzmaterial) 26.04.2024 / 17:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Porsche AG startet entschlossen in das Jahr der Modelloffensiven Operatives Konzernergebnis von 1,28 Milliarden Euro Operative Konzernumsatzrendite liegt bei 14,2 Prozent Anläufe der neuen Panamera- und Taycan-Modelle beeinflussen Ergebnis Finanzvorstand Lutz Meschke: „Auch in herausfordernden Z...
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary Gene...
Relief Therapeutics Holding SA / Key word(s): AGMEGM RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting 26.04.2024 / 17:30 CET/CEST RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting of Shareholders Shareholders approved all proposals by a large majority GENEVA (APR. 26, 2024) – (SIX: , OTCQB: , ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, announces the results of the extraordinary general ...
Mobico Group Plc: 1 director
A director at Mobico Group Plc bought 93,467 shares at 53p and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- ABGSC Capital Goods Research
- Henric Hintze
BioSenic publie sur son site web le plan de restructuration soumis au ...
BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE Mont-Saint-Guibert, Belgique, le 26 avril 2024 à 17h30 CEST – (Euronext Bruxelles et Paris: BIOS), la société en phase clinique spécialisée dans les maladies auto-immunes et inflammatoires graves, dans le cadre du plan de restructuration global annoncé le 11 avril 2024, annonce aujourd'hui la publication sur son site internet de la documentation suivante : Le plan de restructuration couvrant les années 2024-2030 soumis au Tribunal...
BioSenic publishes on its website the restructuring plan submitted to ...
BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles PRESS RELEASE - PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 26 April 2024, 17:30 CET – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases, as part of the global restructuring plan announced on 11 April 2024, today announces the publication on its website of the following documentation : The restructuring plan covering the years 2024-2030 submitted to the Enterprise Court of Nivelles – accessible via th...
Moody's Ratings revises Great Lakes' outlook to stable; affirms B2 CFR
Moody's Ratings (Moody's) affirmed Great Lakes Dredge & Dock Corporation's ("Great Lakes") B2 Corporate Family Rating (CFR), its B2-PD probability of default rating ("PDR"). The rating on the company's senior unsecured notes was downgraded to Caa1 from B3. The speculative grade liquidity ("SGL") rat...
Moody's Ratings affirms Arcosa's Ba2 CFR; outlook stable
Moody's Ratings (Moody's) affirmed Arcosa, Inc.'s (Arcosa) Ba2 corporate family rating (CFR), its Ba2-PD probability of default rating (PDR), and the Ba2 rating on its senior unsecured notes rating. The speculative grade liquidity ("SGL") rating of SGL-2 is unchanged. The rating outlook is maintaine...
MSCI Inc: 2 directors
Two Directors at MSCI Inc bought 20,500 shares at between 459.410USD and 465.920USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Moody's Ratings assigns a definitive rating to TITRISOCRAM 2024
Moody's Ratings ( Moody's) has assigned the following definitive rating to the Notes issued by Titrisocram 2024: ....EUR440M Class A Asset Backed Floating Rate Notes due March 2039, Definitive Rating Assigned Aaa (sf) Moody's has not assigned a rating to the subordinated EUR46.8M Class B Asset B...
Moody's Ratings affirms CA Immo Baa3 rating; outlook stable
Moody's Ratings (Moody's) has today affirmed the Baa3 long term issuer and senior unsecured ratings of CA Immobilien Anlagen AG ("CA Immo"). The outlook changed to stable from negative. RATINGS RATIONALE The Baa3 rating for CA Immobilien Anlagen AG (CA Immo) is bolstered by its prime office port...
- Dan Salmon
Pinterest (PINS, Buy, raising target to $52 from $48) Quick Thoughts ...
We review the setup for the stock and key controversies, including: 1. AMZN, GOOGL and how material 3P revenue becomes in 1Q24 and beyond 2. China impact begins to ease, but less exposure than META We also review what to listen for on the earnings call, our top questions for management, and potential positive & negative catalysts for PINS.
Moody's Ratings affirms Ba1 long-term deposit ratings of Absa Mauritiu...
Moody's Ratings ("Moody's") has today affirmed the Ba1/NP long- and short-term deposit ratings of Absa Bank (Mauritius) Limited (Absa Mauritius) and maintained the stable outlook on the long-term deposit ratings. At the same time, the rating agency has affirmed the bank's ba2 Baseline Credit Assessm...
Winner of Hong Kong’s Flagship Global Elevator Pitch Competition Crown...
EQS Newswire / 26/04/2024 / 17:00 CET/CEST Circular economy battery startup tozero GmbH walks away with the title of overall champion of the EPiC 2024 tozero GmbH crowned as EPiC 2024 champion claiming the top cash prize of US$90,000, 1,100,000 Asia Miles, as well as invaluable investor exposure and partnership opportunities The EPiC 2024 competition breaks new ground as the Grand Finale caps off the first-ever four-city semi-final series across the U.S., Europe and Asia EPiC 2024 attracted a total of 603 contestants from 47 economies solidifying Hong Kong's unique...
Itsec Asia Tbk PT: 1 director
A director at Itsec Asia Tbk PT maiden bought 4,762,300 shares at 298.000IDR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Lifco AB: 1 director
A director at Lifco AB bought 2,000 shares at 262.600SEK and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.